Laman Utama8086 • TYO
add
Nipro Corp
Tutup sebelumnya
¥1,417.00
Julat hari
¥1,414.00 - ¥1,426.50
Julat tahun
¥1,070.50 - ¥1,480.00
Permodalan pasaran
243.39B JPY
Bilangan Purata
696.55K
Nisbah P/E
27.68
Hasil dividen
1.76%
Pertukaran utama
TYO
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(JPY) | Jun 2024info | Perubahan T/T |
---|---|---|
Hasil | 152.39B | 8.39% |
Perbelanjaan pengendalian | 40.10B | 12.23% |
Pendapatan bersih | 2.63B | -35.94% |
Margin untung bersih | 1.72 | -41.10% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 20.53B | 5.13% |
Kadar cukai berkesan | 50.72% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(JPY) | Jun 2024info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 83.60B | -5.06% |
Jumlah aset | 1.14T | 9.23% |
Jumlah liabiliti | 852.26B | 7.68% |
Jumlah ekuiti | 284.44B | — |
Syer tertunggak | 163.10J | — |
Harga kepada buku | 0.94 | — |
Pulangan pada aset | 1.29% | — |
Pulangan pada modal | 1.58% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(JPY) | Jun 2024info | Perubahan T/T |
---|---|---|
Pendapatan bersih | 2.63B | -35.94% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Nipro Corporation is a Japanese medical equipment manufacturing company. Founded in 1954, the company is headquartered in Osaka and is listed on the Tokyo Stock Exchange and the Osaka Securities Exchange.
As of 2013 the company has 58 subsidiaries in Japan, Asia, North and South America and Europe. February 2018, the Company enters the endoscope-related business by making Machida Corporation its subsidiary.
April 1, 2019, the ethical pharmaceutical sales division of subsidiary Nipro ES Pharma Corporation is integrated into our domestic business division, Pharmaceutical Sales Division.
April 1, 2023, the Company's head office will be relocated to a new building constructed on the Company's own land in Kento Innovation Park in Settsu City. The registered head office and the location of the manufacturing and sales office based on the Law Concerning Assurance of Quality, Efficacy and Safety of Pharmaceuticals, Medical Devices and Other Products are scheduled to be relocated in October of the same year. Wikipedia
Diasaskan
8 Jul 1954
Tapak web
Pekerja
38,117